Science 262:68995, PMID: 7901908 Beal MF (1995) Aging, energy, and oxidative stress in neurodegenerative diseases
Research indicates that DSIP administration enhances slow-wave amplitude and continuity in animal EEG studies, providing deeper, more restorative sleep
Zepbound (tirzepatide) is approved for weight loss, while Ozempic (semaglutide) is approved for type 2 diabetes, though in some cases it may be prescribed off-label for weight loss
For a complete breakdown of how storage conditions affect different peptides, review the peptide storage guide
Food & Drug Administration and are not intended to diagnose, treat, cure, or prevent any disease
Typical schedules include: Once weekly for gradual, steady support Twice weekly for accelerated results during initial weeks Monthly maintenance after reaching target goals Your provider will recommend a schedule based on your body composition goals and response to treatment